Evidence map›Paper›PMID 35709537›Full record

ArticleRedox biology2022

On the origin of nitrosylated hemoglobin in COVID-19: Endothelial NO capture or redox conversion of nitrite?: Experimental results and a cautionary note on challenges in translational research.

Renato C Nogueira, Magdalena Minnion, Anna D Clark, Alex Dyson, José E Tanus-Santos, Martin Feelisch

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Renato C NogueiraDepartment of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Brazil; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
Magdalena MinnionClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
Anna D ClarkClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK; Southampton NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK.
Alex DysonCentre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
José E Tanus-SantosDepartment of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Brazil.
Martin FeelischClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK; Southampton NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK. Electronic address: m.feelisch@soton.ac.uk.
Universidade de São Paulo · BRUniversity Hospital Southampton NHS Foundation Trust · GBKing's College London · GBUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In blood, the majority of endothelial nitric oxide (NO) is scavenged by oxyhemoglobin, forming nitrate while a small part reacts with dissolved oxygen to nitrite; another fraction may bind to deoxyhemoglobin to generate nitrosylhemoglobin (HbNO) and/or react with a free cysteine to form a nitrosothiol. Circulating nitrite concentrations in healthy individuals are 200-700 nM, and can be even lower in patients with endothelial dysfunction. Those levels are similar to HbNO concentrations ([HbNO]) recently reported, whereby EPR-derived erythrocytic [HbNO] was lower in COVID-19 patients compared to uninfected subjects with similar cardiovascular risk load. We caution the values reported may not reflect true (patho)physiological concentrations but rather originate from complex chemical interactions of endogenous nitrite with hemoglobin and ascorbate/N-acetylcysteine. Using an orthogonal detection method, we find baseline [HbNO] to be in the single-digit nanomolar range; moreover, we find that these antioxidants, added to blood collection tubes to prevent degradation, artificially generate HbNO. Since circulating nitrite also varies with lifestyle, dietary habit and oral bacterial flora, [HbNO] may not reflect endothelial activity alone. Thus, its use as early marker of NO-dependent endothelial dysfunction to stratify COVID-19 patient risk may be premature. Moreover, oxidative stress not only impairs NO formation/bioavailability, but also shifts the chemical landscape into which NO is released, affecting its downstream metabolism. This compromises the endothelium's role as gatekeeper of tissue nutrient supply and modulator of blood cell function, challenging the body's ability to maintain redox balance. Further studies are warranted to clarify whether the nature of vascular dysfunction in COVID-19 is solely of endothelial nature or also includes altered erythrocyte function.

Indexed as

COVID-19NitritesElectron Spin Resonance SpectroscopyEndotheliumHemoglobinsHumansNitric OxideOxidation-ReductionTranslational Research, BiomedicalHemoglobinsNitric OxideNitritesAscorbateHemoglobinNitric oxideNitriteOxidative stressThiols

Identifiers

PMID35709537
PMCPMC9181201
OpenAlexW4281750230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.